Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021

Glatman-Freedman, Aharona; Hershkovitz, Yael; Kaufman, Zalman; Dichtiar, Rita; Keinan-Boker, Lital; Bromberg, Michal

doi:10.3201/eid2711.211886

i

Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021

Supporting Files Public Domain

11 2021
By Glatman-Freedman, Aharona ; Hershkovitz, Yael ; Kaufman, Zalman ; ...

File Language:

English

Details

Alternative Title:

Emerg Infect Dis
Personal Author:

Glatman-Freedman, Aharona ; Hershkovitz, Yael ; Kaufman, Zalman ; Dichtiar, Rita ; Keinan-Boker, Lital ; Bromberg, Michal
Description:

In Israel, the BNT162b2 vaccine against severe acute respiratory syndrome coronavirus 2 was approved for use in adolescents in June 2021, shortly before an outbreak of B.1.617.2 (Delta) variant-dominant infection. We evaluated short-term vaccine effectiveness and found the vaccine to be highly effective among this population in this setting.
Subjects:

Adolescent Coronavirus Infections Covid-19 Covid-19 Vaccines Disease Outbreaks Humans Sars-Cov-2 Vaccines
Source:

Emerg Infect Dis. 27(11):2919-2922
Pubmed ID:

34570694
Pubmed Central ID:

PMC8544958
Document Type:

Journal Article
Place as Subject:

Israel
Volume:

27
Issue:

11
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

urn:sha256:5850ab60df3913a9bfc815d7c2e35088de6c2fa0b6547756e68ae3bd99815e79
Download URL:

https://stacks.cdc.gov/view/cdc/111460/cdc_111460_DS1.pdf
File Type:

[PDF - 1.46 MB ]

File Language:

English

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.